课题基金 / 基金详情

项目摘要

项目成果

SEAN M BERENHOLTZ的其他基金

相似基金

相关文献

中文摘要
翻译
这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金, 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 骨科手术,特别是脊柱手术,可能会导致大量失血,需要异体输血。异体输血与发病率和成本增加有关。由于其安全性和易于给药,抗纤溶药物是一种有吸引力的减少输血的策略。这项研究提案的主要目标是确定氨基己酸(EACA)是否是一种安全有效的策略,可以降低182名接受脊柱手术的成人患者异体输血的发病率和费用。具体目标和相关假设是:目标1:评估EACA在减少182名在约翰·霍普金斯医院接受脊柱手术的患者中异体输血需求的有效性和安全性。为了实现我们的目标,我们将在182名接受选择性脊柱融合术的患者中进行EACA与安慰剂的随机、双盲对照试验。约翰霍普金斯医院采用植骨融合脊柱融合术和/或内固定手术(ICD-0-CM 754.2)。我们假设接受EACA的患者比接受安慰剂的患者需要的同种异体输血少30%,而血栓并发症没有增加。如果EACA是减少接受脊柱手术的成年患者异体输血需求的有效策略,那么患者的暴露和与异体输血相关的风险将会减少。目的2:评估EACA对约翰·霍普金斯医院脊柱手术患者的经济结果的影响,包括住院时间(LOS)和住院直接费用。为了实现我们的目标,我们将比较干预组和控制组的直接医疗费用。我们假设EACA的直接成本低于对照组。这是一项重要的研究,因为医院护理的成本越来越受到关注。因此有必要对新的治疗方法进行经济评估,例如我们建议在脊柱手术患者中使用氨基己酸的试验。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Orthopedic surgery, particularly spine surgery, can be associated with dramatic blood loss requiring allogeneic blood transfusions. Allogeneic transfusion is associated with morbidity and increased costs. Because of their safety and ease of administration, antifbrinolystic drugs represent an attractive strategy to reduce transfusions. The primary goals of this research proposal is to determine whether epsilon aminocaproic acid (EACA) is a safe and effective strategy to reduce the morbidity and costs associated with allogeneic blood transfusion in 182 adult patients undergoing spine surgery. The specific aims and related hypothesis are: AIM 1: Assess the efficacy and safety of EACA in reducing allogeneic blood transfusion requirements in 182 patients undergoing spine surgery at Johns Hopkins Hospital. To accomplish our aim, we will conduct a randomized, double masked, controlled trial of EACA versus placedbo in 182 patients undergoing elective spinal fusion. Arthrodesis of spine with bone graft bone graft, and/or internal fixation surgery (ICD-0-CM 754.2) at Johns Hopkins Hospital. We hypothesize that patients receiving EACA will require 30% fewer allogeneic transfusions than patients receiving placebo without an increase in thrombotic complication. If EACA is an effective strategy to reduce allogeneic transfusions requirements in adult patients undergoing spine surgery, patient exposure and the risks associated with allogeneic blood transfusion would be decreased. AIM 2: Evaluate the impactr of EACA on economic outcomes, including hospital length of stay (LOS) and direct costs of hospital care in patients undergoing spine surgery at Johns Hopkins Hospital. To accomplish our aim, we will compare the direct costs of medical care in the intervention group versus those in the control group. We hypothesize that the direct costs of EACA are less than those in the control group. This is an important study because the costs of hospital care are increasingly scrutinized. necessitating the economic evaluation of novel therapies such as our proposed trial of epsilon aminocaproic acid in patients undergoing spine surgery.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Engaging Patients and Families to Improve Care for Mechanically Ventilated Patients
  • 批准号:
    8989191
  • 项目类别:
  • 资助金额:
    $18.64万
  • 财政年份:
    2015
  • 负责人:
    SEAN M BERENHOLTZ
  • 依托单位:
Engaging Patients and Families to Improve Care for Mechanically Ventilated Patients
  • 批准号:
    9144357
  • 项目类别:
  • 资助金额:
    $24.02万
  • 财政年份:
    2015
  • 负责人:
    SEAN M BERENHOLTZ
  • 依托单位:
A Multifaceted Intervention to Reduce Ventilator-Associated Pneumonia in the ICU
  • 批准号:
    8278545
  • 项目类别:
  • 资助金额:
    $47.63万
  • 财政年份:
    2011
  • 负责人:
    SEAN M BERENHOLTZ
  • 依托单位:
A Multifaceted Intervention to Reduce Ventilator-Associated Pneumonia in the ICU
  • 批准号:
    8448142
  • 项目类别:
  • 资助金额:
    $45.2万
  • 财政年份:
    2011
  • 负责人:
    SEAN M BERENHOLTZ
  • 依托单位:
海外基金